Search

Our systems are now restored following recent technical disruption, and we’re working hard to catch up on publishing. We apologise for the inconvenience caused. Find out more: https://www.cambridge.org/universitypress/about-us/news-and-blogs/cambridge-university-press-publishing-update-following-technical-disruption

Skip to main content Accessibility help

Home
Search

Only show content I have access to (0)

Chapters (1)

Last 3 years (1)

From year:

To year:

Apply

Medicine (1)

allogeneic

Cambridge University Press (1)

View selected items
Save to my bookmarks
Export citations
Download PDF (zip)
Save to Kindle
Save to Dropbox
Save to Google Drive
Save content to
To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to .

To save content items to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Please be advised that item(s) you selected are not available.
You are about to save
Your Kindle email address

Please provide your Kindle email.

@free.kindle.com @kindle.com (service fees apply)

By using this service, you agree that you will only keep content for personal use, and will not openly distribute them via Dropbox, Google Drive or other file sharing services

1 results

3.10.5 - Malignant Haematology in Intensive Care
from Section 3.10 - Haematological and Oncological Disorders
- By Jenny O’Nions, William Townsend
Edited by Ned Gilbert-Kawai, The Royal Liverpool Hospital, Debashish Dutta, Princess Alexandra Hospital NHS Trust, Harlow, Carl Waldmann, Royal Berkshire Hospital, Reading
Book:

Intensive Care Medicine

Published online:

27 July 2023

Print publication:

01 December 2021, pp 343-352
- Chapter
- - Get access
    
    Check if you have access via personal or institutional login
    
    Log in Register
- Export citation
Summary

Key Learning Points
1. Referral to the ICU should be made, considering the patient’s previous performance score (PS), underlying disease, prognosis and treatment plan, as well as patient wishes. There are no absolute contraindications to ICU admission for haematology patients. A trial of intensive care is usually warranted in patients suitable for life-prolonging therapy.
2. The outcome of ICU admission is largely determined by the acute critical illness, not the underlying haematological malignancy.
3. Patients receiving treatment for haematological malignancies are at high risk of infections and can have immune dysfunction in the absence of cytopenias (recovery of normal neutrophil levels after treatment does not guarantee normal functionality).
4. There are important differences between autologous haematopoietic stem cell transplants and allogeneic HSCT, which impact both complications and prognosis.
5. A tissue biopsy should usually be obtained in patients with suspected haematological malignancy prior to starting steroids. Histological diagnosis is critical in haematological malignancy.